Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × Radiation × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 6 Oropharyngeal Neoplasms 5 Urinary Bladder Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Glioblastoma 3 Carcinoma 3 Astrocytoma 3 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Liposarcoma 2 Leiomyosarcoma 2 Hypopharyngeal Neoplasms 2 Histiocytoma, Malignant Fibrous 2 Glioma 2 Ependymoma 2 Burkitt Lymphoma 2 Adenocarcinoma of Lung 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Sinonasal undifferentiated carcinoma 1 Sinonasal Squamous Cell Carcinoma 1

Interventions

pembrolizumab 29 Paclitaxel 12 Carboplatin 10 Cisplatin 7 Pemetrexed 5 Capecitabine 5 Saline Solution 4 Oxaliplatin 4 Gemcitabine 4 Fluorouracil 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 patritumab deruxtecan 3 Leucovorin 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 liposomal doxorubicin 2 lenvatinib 2 Irinotecan 2 Histamine H2 Antagonists 2 Histamine Antagonists 2 Glucose 2 Dexamethasone 2 Cetuximab 2 Acetaminophen 2 zanidatamab 1 trastuzumab deruxtecan 1 tislelizumab 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡